Team and Development History
Based on the core technology of accelerators, continuously promote the industrialization of medical isotopes.
Company Profile
Yaoke Accelerator Medical Isotope Technology Co., Ltd. is a company focused on the development and application of nuclear medicine based on high-energy, high-current electron accelerators. We concentrate on the core upstream segments of the nuclear medicine industry chain, and based on over a decade of accelerator research and development experience, we independently developed the country's first high-current electron accelerator and supporting target system. This enables the large-scale production of key isotopes such as 225Ac and 99Mo, breaking dependence on imports, and providing stable, efficient raw material supply and technical services for nuclear medicine research and clinical application.
Breaking through isotope production barriers with cutting-edge technology, empowering nuclear medicine innovation, and protecting human health.
Become a global leading supplier of nuclear pharmaceutical raw materials and CRDMO services.
Core team
- PhD from the Institute of High Energy Physics, Chinese Academy of Sciences, with over 10 years of experience in accelerator research and development.
- Former Deputy General Manager of X-ray Equipment R&D, led the development of particle accelerators and industrial CT, and holds over 10 related patents.
- Jiading District's 11th batch of highly in-demand talents focuses on advancing the industrial application of nuclear technology.
- Majored in Nuclear Technology and Applications at the University of Science and Technology of China, with 18 years of experience in accelerator design and development.
- Skilled in accelerator physics design, beam dynamics, and microwave calculations, with extensive experience in the development and commissioning of accelerator tubes.
- Ph.D. in Nuclear Engineering from Ohio State University, over 10 years of experience in radiochemistry.
- Published more than 30 SCI papers, applied for 23 patents (13 granted), and won the First Prize for Technological Invention from the China Nuclear Energy Industry Association in 2021.
Development process
- The core team has completed the accumulation of high-current accelerator technology
- Participated in major national science and technology projects (electron-positron collider, CSNS spallation neutron source)
- Completed the development of core components of the accelerator, with the industrial irradiation accelerator tube achieving the highest power (28 kW) in its domestic category.
- The company was officially established
- Site Selection and Environmental Assessment for Starting a Production Plant
- The accelerator system has entered the debugging phase
- Obtain Class B GMP production qualification
- Complete the construction and acceptance of the isotope accelerator system
- 225Ac and 99Mo officially mass-produced
- Launch nuclear medicine CRDMO business